These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11764966)

  • 1. Structure-activity relationships of cyclotetrapeptides: interaction of tentoxin derivatives with three membrane proteins.
    Loiseau N; Delaforge M; Minoletti C; André F; Garrigues A; Orlowski S; Gomis JM
    Adv Exp Med Biol; 2001; 500():343-6. PubMed ID: 11764966
    [No Abstract]   [Full Text] [Related]  

  • 2. Carrier-mediated transport of macrolide antimicrobial agents across Caco-2 cell monolayers.
    Saito H; Fukasawa Y; Otsubo Y; Yamada K; Sezaki H; Yamashita S
    Pharm Res; 2000 Jun; 17(6):761-5. PubMed ID: 10955854
    [No Abstract]   [Full Text] [Related]  

  • 3. Rebuilt 3D structure of the chloroplast f1 ATPase-tentoxin complex.
    Minoletti C; Santolini J; Haraux F; Pothier J; André F
    Proteins; 2002 Nov; 49(3):302-20. PubMed ID: 12360520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of tentoxin by hepatic cytochrome P-450 3A isozymes.
    Delaforge M; Andre F; Jaouen M; Dolgos H; Benech H; Gomis JM; Noel JP; Cavelier F; Verducci J; Aubagnac JL; Liebermann B
    Eur J Biochem; 1997 Nov; 250(1):150-7. PubMed ID: 9432003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal function and morphology after ex vivo irradiated small bowel transplantation.
    Ishikawa T; Iwanami K; Okuda T; Zhu Y; Fukuda A; Zhang S; Ou J; Nalesnik MA; Venkataramanan R; Murase N
    Transplant Proc; 2002 May; 34(3):988-9. PubMed ID: 12034274
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics and metabolism in early drug discovery.
    Smith DA; van de Waterbeemd H
    Curr Opin Chem Biol; 1999 Aug; 3(4):373-8. PubMed ID: 10419843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of the mechanisms of the drug-drug interaction from a view of pharmacogenomics].
    Sai Y; Tsuji A
    Nihon Rinsho; 2002 Jan; 60(1):74-80. PubMed ID: 11808342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4.
    Cummins CL; Jacobsen W; Benet LZ
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1036-45. PubMed ID: 11861813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-Glycoprotein in clinical cardiology.
    Rodriguez I; Abernethy DR; Woosley RL
    Circulation; 1999 Feb; 99(4):472-4. PubMed ID: 9927391
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4.
    Ohnishi A; Matsuo H; Yamada S; Takanaga H; Morimoto S; Shoyama Y; Ohtani H; Sawada Y
    Br J Pharmacol; 2000 Jul; 130(6):1369-77. PubMed ID: 10903978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basic pharmacological interactions and how they may impact on one another.
    Benet L
    J Acquir Immune Defic Syndr; 2005 Mar; 38 Suppl 1():S22-3. PubMed ID: 15867606
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapeutic drug monitoring of immunosuppresants].
    Hashida T; Inui K
    Rinsho Byori; 2001 Jul; 49(7):662-4. PubMed ID: 11519126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of P450 CYP3A4-dependent metabolism by P-glycoprotein: implications for P450 phenotyping.
    Baron JM; Goh LB; Yao D; Wolf CR; Friedberg T
    J Pharmacol Exp Ther; 2001 Feb; 296(2):351-8. PubMed ID: 11160617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of cytochrome P450 (CYP)1A1, CYP1A2, and CYP3A4 but not of CYP2C9, CYP2C19, multidrug resistance (MDR-1) and multidrug resistance associated protein (MRP-1) by prototypical inducers in human hepatocytes.
    Runge D; Köhler C; Kostrubsky VE; Jäger D; Lehmann T; Runge DM; May U; Stolz DB; Strom SC; Fleig WE; Michalopoulos GK
    Biochem Biophys Res Commun; 2000 Jun; 273(1):333-41. PubMed ID: 10873607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CYP3A4 and P-glycoprotein in drug interactions involving the HMG-CoA reductase inhibitors.
    Mathis S
    J Am Pharm Assoc (Wash); 2001; 41(1):5-6. PubMed ID: 11216112
    [No Abstract]   [Full Text] [Related]  

  • 16. Polarized cell cultures for integrated studies of drug metabolism and transport.
    Brimer-Cline C; Schuetz EG
    Methods Enzymol; 2002; 357():321-9. PubMed ID: 12424922
    [No Abstract]   [Full Text] [Related]  

  • 17. 6',7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein.
    Edwards DJ; Fitzsimmons ME; Schuetz EG; Yasuda K; Ducharme MP; Warbasse LH; Woster PM; Schuetz JD; Watkins P
    Clin Pharmacol Ther; 1999 Mar; 65(3):237-44. PubMed ID: 10096255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies to determine the selective inhibitors for P-glycoprotein and cytochrome P4503A4.
    Achira M; Suzuki H; Ito K; Sugiyama Y
    AAPS PharmSci; 1999; 1(4):E18. PubMed ID: 11741214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1, 1-dimethylethylaminocarbonyl)-4-[(furo[2, 3-b]pyridin-5-yl)methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethy lpentanamide and P-glycoprotein by valspodar in gene transfectant systems.
    Kawahara I; Kato Y; Suzuki H; Achira M; Ito K; Crespi CL; Sugiyama Y
    Drug Metab Dispos; 2000 Oct; 28(10):1238-43. PubMed ID: 10997946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age.
    Fakhoury M; Litalien C; Medard Y; Cavé H; Ezzahir N; Peuchmaur M; Jacqz-Aigrain E
    Drug Metab Dispos; 2005 Nov; 33(11):1603-7. PubMed ID: 16049125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.